Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance.
- NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_assertion description "[MCF-7 human breast cancer cells were treated with inhibitors for PLA2 (quinacrine), lipoxygenases (LOX-5 and LOX-12; baicalein, REV-5091, nordihydroguaiaretic acid), cyclooxygenases (COX-1, COX-2, indomethacin), and AROM (formestane).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance.
- NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_assertion evidence source_evidence_literature NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance.
- NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_assertion SIO_000772 18087590 NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance.
- NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_assertion wasDerivedFrom befree-2016 NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance.
- NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_assertion wasGeneratedBy ECO_0000203 NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance.
- befree-2016 importedOn "2016-02-19" NP645806.RACYjYRkUk_p1wHh7bD7xOsnUDqty-B47oITFoeuTuSqE130_provenance.